The NIHR Invention for Innovation Programme: Funding Translational Research in Healthcare Technologies

As a translational funding scheme, i4i advances healthcare technologies, devices and interventions for increased patient benefit in areas of existing or emerging clinical need.

We fund collaborative R&D projects in medtech SMEs, universities and the NHS that have demonstrated proof-of-principle and have a clear pathway towards adoption and commercialisation. The aim is to de-risk projects, making them attractive to follow-on funders and investors.
The expected i4i output is an advanced or clinically validated prototype medical device, technology or intervention.

Projects must have already demonstrated ‘proof of principle’. Applicants are expected to have generated experimental data to support the case for further development and illustrate technical feasibility. Early stage research or discovery science is not fundable.

Work packages must not include animal studies or work on animal tissues. If animal studies are required as part of the project, we expect applicants to seek parallel funding to cover such studies, details of which can be provided in the application form.